| Company | Date | Position | Consensus β | Price Target β | 2-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
FR
First Industrial Realty
|
Oct 29, 2026 | BUY |
Buy
+9.8% avg upside
27 analysts
|
$70.00
28.75% Upside
|
+0.2% | Β· |
|
MPT
Medical Properties Trust
|
Oct 29, 2026 | SELL |
Sell
+429.6% avg upside
24 analysts
|
$2.00
11.08% Downside
|
+25.8% | Β· |
|
PLD
Prologis
|
Oct 29, 2026 | BUY |
Buy
+14.5% avg upside
33 analysts
|
$160.00
25.06% Upside
|
+0.5% | Β· |
|
COLD
Americold Realty
|
Oct 13, 2026 | HOLD |
Buy
+27.7% avg upside
24 analysts
|
β | +19.2% | Β· |
|
HR
Healthcare Realty Trust
|
Oct 08, 2026 | HOLD |
Hold
+17.5% avg upside
25 analysts
|
$22.00
18.92% Upside
|
+13.8% | Β· |
|
CTRE
CareTrust REIT
|
Oct 02, 2026 | HOLD |
Strong Buy
-1.9% avg upside
22 analysts
|
$43.00
18.18% Upside
|
+5.1% | Β· |
|
NHP
National Healthcare Properties
|
Oct 01, 2026 | HOLD |
Buy
+23.5% avg upside
9 analysts
|
$17.00
12.74% Upside
|
-4.1% | Β· |
|
LTC
LTC Properties
|
Oct 01, 2026 | BUY |
Buy
-14.7% avg upside
16 analysts
|
$52.00
16.27% Upside
|
+3.0% | Β· |
|
LINE
Lineage, Inc.
|
Sep 30, 2026 | BUY |
Hold
+22.1% avg upside
23 analysts
|
$48.00
33.36% Upside
|
+2.4% | Β· |
|
OHI
Omega Healthcare
|
Sep 11, 2026 | HOLD |
Buy
-6.3% avg upside
30 analysts
|
$51.00
8.55% Upside
|
+4.5% | Β· |
|
DEA
Easterly Government Properties
|
Aug 21, 2026 | SELL |
Hold
+12.8% avg upside
11 analysts
|
$24.00
7.48% Upside
|
+9.3% | Β· |
|
DHC
Diversified Healthcare Trust
|
Aug 21, 2026 | HOLD |
Hold
+43.5% avg upside
11 analysts
|
$8.00
2.90% Upside
|
-11.2% | Β· |
|
VTR
Ventas
|
Aug 14, 2026 | BUY |
Strong Buy
-0.9% avg upside
36 analysts
|
$99.00
16.68% Upside
|
-2.2% | Β· |
|
AHR
American Healthcare REIT, Inc.
|
Aug 14, 2026 | BUY |
Strong Buy
+5.0% avg upside
17 analysts
|
$61.00
14.04% Upside
|
+6.9% | Β· |
|
JAN
Janus Living, Inc. Class A
|
Aug 10, 2026 | BUY |
Strong Buy
+16.5% avg upside
13 analysts
|
$34.00
19.19% Upside
|
+7.3% | Β· |
|
ARE
Alexandria Equities
|
Aug 10, 2026 | HOLD |
Hold
+82.4% avg upside
26 analysts
|
$51.00
26.85% Upside
|
-3.7% | Β· |
|
DOC
Healthpeak Properties
|
Aug 10, 2026 | BUY |
Strong Buy
+24.7% avg upside
44 analysts
|
$24.00
26.11% Upside
|
-1.0% | Β· |
|
EPR
EPR Properties
|
Aug 07, 2026 | HOLD |
Buy
+11.6% avg upside
22 analysts
|
$64.00
10.81% Upside
|
-0.1% | Β· |
|
KRC
Kilroy Realty
|
Aug 04, 2026 | BUY |
Hold
+28.4% avg upside
26 analysts
|
$43.00
19.26% Upside
|
-7.3% | Β· |
|
STAG
Stag Industrial
|
Jul 31, 2026 | HOLD |
Buy
+3.2% avg upside
27 analysts
|
$42.00
13.88% Upside
|
-2.4% | Β· |
|
WELL
Welltower
|
Jul 31, 2026 | BUY |
Strong Buy
-15.9% avg upside
34 analysts
|
$260.00
10.83% Upside
|
+6.3% | Β· |
|
EGP
Eastgroup Properties
|
Jul 31, 2026 | HOLD |
Strong Buy
+2.4% avg upside
31 analysts
|
$220.00
10.70% Upside
|
-4.8% | Β· |
|
ILPT
Industrial Logistics Properties
|
Aug 01, 2023 | HOLD |
Sell
+126.7% avg upside
8 analysts
|
$5.00
26.55% Downside
|
+41.2% | Β· |
|
AAT
American Assets
|
Jul 02, 2020 | BUY |
Hold
+64.7% avg upside
8 analysts
|
$41.00
87.64% Upside
|
+14.9% | Β· |
|
BXP
BXP
|
Nov 27, 2019 | BUY |
Buy
+30.9% avg upside
35 analysts
|
$148.00
135.67% Upside
|
-13.1% | Β· |
|
NNN
NNN REIT
|
Dec 14, 2018 | HOLD |
Hold
+11.9% avg upside
29 analysts
|
$50.00
21.88% Upside
|
-13.5% | Β· |
|
SUI
Sun Communities
|
Oct 26, 2017 | BUY |
Buy
+17.5% avg upside
22 analysts
|
$96.00
15.24% Downside
|
+85.4% | Β· |
|
SBRA
Sabra Healthcare REIT
|
Jan 27, 2014 | BUY |
Buy
+1.3% avg upside
30 analysts
|
$33.00
67.14% Upside
|
-28.7% | Β· |
|
PDM
Piedmont Office
|
Mar 24, 2010 | BUY |
Buy
+49.3% avg upside
7 analysts
|
$22.00
129.22% Upside
|
+4.0% | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.